Trial intelligence / Profile preview

Pramipexole for Chronic Pain

NCT03842709Phase 1Completed

Sponsor
The University of New Mexico
Start
May 2019
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in chronic pain comparing Placebo with Pramipexole (2 arms). Primary endpoint: Brief Pain Inventory Score at 4 weeks. Started May 2019; status: completed.

02

Drugs

pramipexole
03

Conditions

chronic pain

Beyond the preview

Go deeper on NCT03842709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03842709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call